NCT05619302View on ClinicalTrials.gov

Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis

PHASE3RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 30, 2025

Conditions
Cardiac Amyloidosis
Interventions
DRUG

[68Ga]CBP8 PET/MRI

Simultaneous cardiac PET/MRI images will be obtained following injection of \[68Ga\]CBP8

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER